Home
GSC Biological and Pharmaceutical Sciences
Peer-reviewed Journal | Impact factor 8.1 | ISSN: 2581-3250 | CAS Source Indexed | Crossref DOI

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Research and review articles are invited for publication in September 2026 - Vol. 36, Issue 3 

🌟 GSC Biological and Pharmaceutical Sciences (GSCBPS) 🌟

Low Publication Charges | Fast Editorial Processing | Crossref DOI Linking | Transparent Peer-Review Process

Publishing quality research in Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare and Allied Life Sciences.

e-ISSN: 2581-3250 | Impact Factor: 8.1 | Established: 2017 | Charges: USD 35 / INR 2100

📄 Submit Manuscript 👉 Author Guidelines 📚 Published Articles 

Epistaxis: A prospective clinical study

Breadcrumb

  • Home
  • Epistaxis: A Prospective Clinical Study
  • Epistaxis: A prospective clinical study

Ausama Fahmy Al-Banna *

Department of Surgery, ENT unit, AL- Sheikhan general hospital, Mosul, Iraq.
Research Article
GSC Biological and Pharmaceutical Sciences, 2025, 30(03), 347-357.
Article DOI: 10.30574/gscbps.2025.30.3.0123
DOI url: https://doi.org/10.30574/gscbps.2025.30.3.0123
Received on 12 February 2025; revised on 21 March 2025; accepted on 24 March 2025
Epistaxis is one of the most common ear, nose and throat (ENT) emergencies to present to general practitioners. Epistaxis may be simple and readily treatable condition but it sometimes led to potential consequences of sever and life-threatening bleeding. 160 patients 88 were males and 72 were females complained from epistaxis who had consulted the Ear, Nose and Throat (E.NT.) department at Al-Sheikhan Hospital for the period from September (2023) to December (2024) were recorded in the study. They were asked in specially-constructed questionnaire about age, sex, history and full general and otolaryngological examination and laboratory and radiological investigation if indicated.
Conclusion The current study concluded that there is a slight male dominance in sex distribution. The secondary causes of epistaxis were slightly commoner than the primary one. The anterior bleeding is the commonest site of epistaxis. Recurrent epistaxis was usually minor, non-life-threatening and often easily managed while acute epistaxis was usually severe. There is a significant relationship between secondary epistaxis and the age of patients. Traumatic factor is the most common local cause, anticoagulant medications are the most common systemic cause. There is a significant relationship of hypertension with the site and the aetiology of epistaxis. Nasal endoscopy is very helpful procedure for better assessment and evaluation of posterior epistaxis.
Epistaxis; Social Habit; Etiology; 2ry Causes
https://gscbps.gsconlinepress.com/sites/default/files/fulltext_pdf/GSCBPS-2025-…

Preview Article PDF

Ausama Fahmy Al-Banna. Epistaxis: A prospective clinical study. GSC Biological and Pharmaceutical Sciences, 2025, 30(3), 347-357. Article DOI: https://doi.org/10.30574/gscbps.2025.30.3.0123


📝 Copyright, Licensing and Permissions: © Copyright Author(s). This article is published under the 🌐 Creative Commons Attribution 4.0 International License (CC BY 4.0) , which permits unrestricted use, distribution, adaptation, and reproduction in any medium, provided the original author(s) and source are properly credited, a link to the license is provided, and any changes made are indicated.


⚠️ Disclaimer: The statements, opinions, interpretations, and data presented in this publication are solely those of the individual author(s). GSC Biological and Pharmaceutical Sciences (GSCBPS), the editors, reviewers, editorial board, and publisher disclaim responsibility for any errors, omissions, or consequences arising from the use of the information contained in this article.


🏆 Get Publication Certificate 📄 Download Letter of Acceptance 🔗 Verify Crossref DOI 📘 View Issue Cover Page 👨‍🔬 Editorial Board 📑 Table of Contents 

🚀 Publish Your Research in International Peer Reviewed Open Access Journal - GSC Biological and Pharmaceutical Sciences (GSCBPS)

Submit your manuscripts from Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare, Biotechnology and Allied Life Sciences etc.

🌍 International Journal   |   👨‍🔬 Transparent Peer Review Process   |   🌐 Open Access Publishing   |   🔗 Crossref DOI 
⚡ Fast Editorial Processing   |   💰 Low Publication Charges

📝 Submit Your Manuscript 📘 Author Guidelines 💰 Publication Charges 

✅ No Submission Fee •  📜 Free Publication Certificate • 🌍 Global Visibility

⭐ Popular Pages


  • 🌍 International Journal
  • 🌐 Open Access Journal
  • 👨‍⚖️ Peer-Reviewed Journal
  • 💰 Low APC Journal
  • 🚀 Fast Publication Journal
  • ⚡ Fast-Track Peer-Review
  • 🔗 Crossref DOI Journal
  • 📖 Refereed Journal
  • 📈 High Impact Journal
  • 🧬 International Biology Journal
  • 💊 International Pharmacy Journal
  • 📝 Publish Research Paper

✍️ Author Resources


  • 📝 Publish Research Paper
  • 📖 Author Guidelines
  • 🎯 Aims and Scope
  • 💳 Article Processing Charges
  • 📤 Submit Manuscript
  • 📄 Cover Letter
  • ✍️ Author Declaration Form
  • 📄Track Manuscript Status
  • 📜 Get Publication Certificate
  • 📚 Journal Past Issue Archive
  • 🔎 Journal Indexing

⚖️ Journal Policies


  • ⚖️ Publication Ethics
  • 🛡️ Plagiarism Policy
  • 👨‍🔬 Peer Review Policy
  • 👨‍⚖️ Peer Review Process
  • 📖 Open Access Publishing
  • 📜 Copyright & Licensing
  • 🔗Author Self-Archiving Policy
  • 👥 Authorship Policy
  • 📊 Data Sharing Policy
  • 🤖 AI Usage Policy

Copyright © 2026 GSC Biological and Pharmaceutical Sciences - All rights reserved

Developed & Designed by VS Infosolution